{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:40:24Z","timestamp":1791646824645,"version":"4.3.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extracardiac complications (ECCs) contribute to morbidity and mortality in patients with infective endocarditis (IE). Current guidelines recommend 18F-fluorodeoxyglucose positron emission tomography\/computed tomography (18F-FDG-PET\/CT) as a screening tool for ECCs. This study assessed the clinical impact of ECCs detected by 18F-FDG-PET\/CT compared to conventional diagnostics in patients with suspected IE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with possible or definite IE (European Society of Cardiology 2015 criteria) were prospectively enrolled in the Amsterdam UMC endocarditis team registry from October 2016 till March 2021. The primary outcome, the number of source control interventions (SCIs), was analyzed using Cox regression analyses extended for recurrent events, with 18F-FDG-PET\/CT as a time-dependent covariate. Secondary outcomes included the crude number needed to scan to perform 1 additional SCI, predictors associated with SCIs, and 90-day all-cause mortality adjusted for both immortal time bias and confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 252 patients, 152 in the 18F-FDG-PET\/CT group and 100 in the control group. In the control group, 18 SCIs were performed. In the 18F-FDG-PET\/CT group, 57 SCIs were performed, of which 21 were prompted by 18F-FDG-PET\/CT findings. The crude number needed to scan leading to 1 additional SCI was 8 (95% confidence interval [CI], 6\u201315). 18F-FDG-PET\/CT was associated with the number of SCIs, with an adjusted hazard ratio (aHR) of 2.96 (95% CI, 1.36\u20136.44). No variables were significantly associated with 18F-FDG-PET\/CT-related SCIs. No differences were found in mortality between the control and PET\/CT group (aHR, 0.69 [95% CI, .40\u20131.20]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of 18F-FDG-PET\/CT among patients with suspected IE leads to increased SCIs for ECCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag140","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:27:18Z","timestamp":1773858438000},"source":"Crossref","is-referenced-by-count":1,"title":["18F-FDG-PET\/CT Leads to Improved Source Control of Extracardiac Complications in Infective Endocarditis"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-4627","authenticated-orcid":false,"given":"Sabrine","family":"Douiyeb","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Institute for Immunology and Infectious Diseases , Infectious Diseases, Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"van Gameren","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Meander Medical Center , Amersfoort ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-8670","authenticated-orcid":false,"given":"David","family":"Buis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Institute for Immunology and Infectious Diseases , Infectious Diseases, Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5873-0474","authenticated-orcid":false,"given":"Thomas","family":"van der Vaart","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]},{"name":"Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0861-0765","authenticated-orcid":false,"given":"Matthijs","family":"Boekholdt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Selder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Robbers-Visser","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3774-2414","authenticated-orcid":false,"given":"Hein","family":"Verberne","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, University of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"van Werkhoven","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Sigaloff","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Institute for Immunology and Infectious Diseases , Infectious Diseases, Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5415-8933","authenticated-orcid":false,"given":"Jan","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026041703020875400_ofag140-B1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2334-11-48","article-title":"Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system","volume":"11","author":"Fedeli","year":"2011","journal-title":"BMC Infect Dis"},{"key":"2026041703020875400_ofag140-B2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejim.2016.05.021","article-title":"The increasing incidence of infective endocarditis in Denmark, 1994\u20132011","volume":"35","author":"Erichsen","year":"2016","journal-title":"Eur J Intern Med"},{"key":"2026041703020875400_ofag140-B3","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","article-title":"Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study","volume":"40","author":"Habib","year":"2019","journal-title":"Eur Heart J"},{"key":"2026041703020875400_ofag140-B4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0735-1097(02)01790-4","article-title":"Risk of embolization after institution of antibiotic therapy for infective endocarditis","volume":"39","author":"Vilacosta","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026041703020875400_ofag140-B5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00330-008-1037-3","article-title":"Radiologic manifestations of extra-cardiac complications of infective endocarditis","volume":"18","author":"Colen","year":"2008","journal-title":"Eur Radiol"},{"key":"2026041703020875400_ofag140-B6","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"2026041703020875400_ofag140-B7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmi.2014.08.012","article-title":"The role of FDG-PET\/CT imaging in early detection of extra-cardiac complications of infective endocarditis","volume":"21","author":"Orvin","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2026041703020875400_ofag140-B8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0735-1097(00)01206-7","article-title":"Echocardiography predicts embolic events in infective endocarditis","volume":"37","author":"Di Salvo","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026041703020875400_ofag140-B9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/ehjci\/jeu054","article-title":"Clinical impact of 18F-FDG-PET\/CT in the extra cardiac work-up of patients with infective endocarditis","volume":"15","author":"Asmar","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026041703020875400_ofag140-B10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00259-013-2426-7","article-title":"(1)(8)F-FDG PET\/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis","volume":"40","author":"Bonfiglioli","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026041703020875400_ofag140-B11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10554-020-01787-8","article-title":"Clinical usefulness of FDG-PET\/CT for identification of abnormal extra-cardiac foci in patients with infective endocarditis","volume":"36","author":"Holle","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026041703020875400_ofag140-B12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00259-010-1380-x","article-title":"(18)F-FDG PET\/CT for early detection of embolism and metastatic infection in patients with infective endocarditis","volume":"37","author":"Van Riet","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026041703020875400_ofag140-B13","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"2026041703020875400_ofag140-B14","volume-title":"SWAB guidelines for the antimicrobial treatment of infective endocarditis","author":"van der Vaart","year":"2019"},{"key":"2026041703020875400_ofag140-B15","doi-asserted-by":"crossref","first-page":"e068295","DOI":"10.1136\/bmjopen-2022-068295","article-title":"Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment","volume":"13","author":"Buis","year":"2023","journal-title":"BMJ Open"},{"key":"2026041703020875400_ofag140-B16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox's regression model for counting processes: a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"2026041703020875400_ofag140-B17","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/eurheartj\/ehs379","article-title":"Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis","volume":"34","author":"L\u00f3pez","year":"2013","journal-title":"Eur Heart J"},{"key":"2026041703020875400_ofag140-B18","doi-asserted-by":"crossref","first-page":"E522","DOI":"10.1111\/1469-0691.12033","article-title":"Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital","volume":"18","author":"Fernandez-Hidalgo","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026041703020875400_ofag140-B19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2967\/jnumed.113.134981","article-title":"Role of (18)F-FDG PET in patients with infectious endocarditis","volume":"55","author":"Kestler","year":"2014","journal-title":"J Nucl Med"},{"key":"2026041703020875400_ofag140-B20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-023-04557-1","article-title":"Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss university hospital and the role of early source control; a retrospective cohort study","volume":"42","author":"Papadimitriou-Olivgeris","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026041703020875400_ofag140-B21","doi-asserted-by":"crossref","DOI":"10.21470\/1678-9741-2025-0151","article-title":"Utility of the charlson comorbidity index in the preoperative evaluation of patients undergoing cardiac surgery","volume":"41","author":"Manzur-Sandoval","year":"2026","journal-title":"Braz J Cardiovasc Surg"},{"key":"2026041703020875400_ofag140-B22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciad112","article-title":"Positive impact of [18F]FDG-PET\/CT on mortality in patients with Staphylococcus aureus bacteremia explained by immortal time bias","volume":"77","author":"van der Vaart","year":"2023","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag140\/67392562\/ofag140.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag140\/68099301\/ofag140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag140\/68099301\/ofag140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:02:22Z","timestamp":1776409342000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag140\/8527920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag140","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,18]]},"article-number":"ofag140"}}